Condensed Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Treasury Stock	Noncontrolling Interests in Subsidiaries	Total
Cumulative effect of adoption of ASU 2014-09				$ (24,359)			$ (24,359)
Adjusted balance	$ 442	$ 184,785	$ (2,117)	267,892	$ (597,072)	$ 15,757	(130,313)
Balance at Dec. 31, 2017	$ 442	184,785	(2,117)	292,251	(597,072)	15,757	(105,954)
Balance (in shares) at Dec. 31, 2017	33,931
Net income (loss)				15,342		1,717	17,059
Other comprehensive income (loss)			6,177				6,177
Adoption of ASU 2018-02			(455)	455
Cash dividends on common stock		109		(21,850)			(21,741)
Exercise of stock options	$ 1	2,592					2,593
Exercise of stock options (in shares)	73
Tax effect of equity awards		(1,474)					(1,474)
Acquisition of Company common stock					(158,049)		(158,049)
Acquisition of Company common stock (in shares)	(2,698)
Stock-based compensation expense		7,073					7,073
Issuance of restricted stock		(2,893)			2,893
Issuance of restricted stock (in shares)	54
Distributions to noncontrolling interests						(2,686)	(2,686)
Other		(57)		2,758	333	621	3,655
Other (in shares)	6
Balance at Sep. 30, 2018	$ 443	190,135	3,605	264,597	(751,895)	15,409	(277,706)
Balance (in shares) at Sep. 30, 2018	31,366
Balance at Jul. 01, 2018	$ 443	188,026	2,240	282,739	(742,694)	16,135	(253,111)
Balance (in shares) at Jul. 01, 2018	31,548
Net income (loss)				(13,300)		818	(12,482)
Other comprehensive income (loss)			1,364				1,364
Cash dividends on common stock		36		(7,093)			(7,057)
Exercise of stock options		413					413
Exercise of stock options (in shares)	18
Tax effect of equity awards		(121)					(121)
Acquisition of Company common stock					(9,609)		(9,609)
Acquisition of Company common stock (in shares)	(207)
Stock-based compensation expense		2,144					2,144
Issuance of restricted stock		(347)			347
Issuance of restricted stock (in shares)	6
Distributions to noncontrolling interests						(1,576)	(1,576)
Other		(16)	1	2,251	61	32	2,329
Other (in shares)	1
Balance at Sep. 30, 2018	$ 443	190,135	3,605	264,597	(751,895)	15,409	(277,706)
Balance (in shares) at Sep. 30, 2018	31,366
Balance at Dec. 30, 2018	$ 443	192,984	(3,143)	242,182	(751,704)	15,225	(304,013)
Balance (in shares) at Dec. 30, 2018	31,372
Net income (loss)				7,008		783	7,791
Other comprehensive income (loss)			(10,753)				(10,753)
Cash dividends on common stock		174		(21,545)			(21,371)
Cash dividends on preferred stock				(6,608)			(6,608)
Dividends declared on preferred stock				(2,273)			(2,273)
Exercise of stock options		332					332
Exercise of stock options (in shares)	12
Tax effect of equity awards		(1,150)					(1,150)
Stock-based compensation expense		12,295					12,295
Issuance of restricted stock		(3,117)			3,117
Issuance of restricted stock (in shares)	54
Distributions to noncontrolling interests						(645)	(645)
Other		(328)		(240)	597		29
Other (in shares)	10
Balance at Sep. 29, 2019	$ 443	201,190	(13,896)	218,524	(747,990)	15,363	(326,366)
Balance (in shares) at Sep. 29, 2019	31,448
Balance at Jun. 30, 2019	$ 443	196,927	(11,196)	228,833	(748,657)	15,584	(318,066)
Balance (in shares) at Jun. 30, 2019	31,427
Net income (loss)				385		241	626
Other comprehensive income (loss)			(2,700)				(2,700)
Cash dividends on common stock		79		(7,182)			(7,103)
Cash dividends on preferred stock				(1,140)			(1,140)
Dividends declared on preferred stock				(2,273)			(2,273)
Exercise of stock options		239					239
Exercise of stock options (in shares)	9
Tax effect of equity awards		(255)					(255)
Stock-based compensation expense		4,764					4,764
Issuance of restricted stock		(547)			547
Issuance of restricted stock (in shares)	10
Distributions to noncontrolling interests						(462)	(462)
Other		(17)		(99)	120		4
Other (in shares)	2
Balance at Sep. 29, 2019	$ 443	$ 201,190	$ (13,896)	$ 218,524	$ (747,990)	$ 15,363	$ (326,366)
Balance (in shares) at Sep. 29, 2019	31,448